Diabetes that can start after acute pancreatitis
Type 1 Diabetes in Acute Pancreatitis Consortium – Pacific Northwest Clinical Center: Immune Pathogenesis of Post-Pancreatitis T1D
This project follows people who had acute pancreatitis to find out how and why diabetes can begin afterward.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Benaroya Research Inst at Virginia Mason NIH-funded |
| Lab location | 1 site (Seattle, United States) |
| Project ID | NIH-11234743 on NIH RePORTER |
What this research studies
If you recently had acute pancreatitis, researchers will enroll you in a long-term follow-up where they collect health information and blood samples over time. The team will use detailed immune testing and diabetes-related hormone measurements to see which kinds of diabetes develop after pancreatitis. Ten clinical centers in a consortium will enroll participants to get a large, consistent picture of risk factors and timing. The goal is to link immune changes and clinical features to the appearance of diabetes so future detection and care can improve.
Who could benefit from this research
Good fit: Ideal candidates are adults recently hospitalized for acute pancreatitis who do not already have established diabetes and are willing to attend follow-up visits and provide blood samples.
Not a fit: People without a history of acute pancreatitis or those with long-standing diabetes unrelated to pancreatic injury are unlikely to benefit directly from this project.
Why it matters
Potential benefit: If successful, this work could help identify people at high risk for diabetes after pancreatitis so they can get earlier monitoring and tailored care.
How similar studies have performed: Previous retrospective studies have reported higher diabetes rates after pancreatitis, but large prospective, immune-focused follow-up like this is relatively new.
Where this research is happening
Seattle, United States
- Benaroya Research Inst at Virginia Mason — Seattle, United States (Active)
Researchers
- Principal investigator: Speake, Cate — Benaroya Research Inst at Virginia Mason
- Study coordinator: Speake, Cate
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.